Table of Content

1 Market Overview

• 1.1 Product Definition and Market Characteristics
• 1.2 Global Cancer Immunotherapy Market Size
• 1.3 Market Segmentation
• 1.4 Global Macroeconomic Analysis
• 1.5 SWOT Analysis

2. Market Dynamics

• 2.1 Market Drivers
• 2.2 Market Constraints and Challenges
• 2.3 Emerging Market Trends
• 2.4 Impact of COVID-19
  • 2.4.1 Short-term Impact
  • 2.4.2 Long-term Impact

3 Associated Industry Assessment

• 3.1 Supply Chain Analysis
• 3.2 Industry Active Participants
  • 3.2.1 Suppliers of Raw Materials
  • 3.2.2 Key Distributors/Retailers
• 3.3 Alternative Analysis
• 3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

• 4.1 Industry Leading Players
• 4.2 Industry News
  • 4.2.1 Key Product Launch News
  • 4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

• 5.1 Takara Bio
  • 5.1.1 Takara Bio Company Profile
  • 5.1.2 Takara Bio Business Overview
  • 5.1.3 Takara Bio Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.1.4 Takara Bio Cancer Immunotherapy Products Introduction
• 5.2 Immunomedics Inc
  • 5.2.1 Immunomedics Inc Company Profile
  • 5.2.2 Immunomedics Inc Business Overview
  • 5.2.3 Immunomedics Inc Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.2.4 Immunomedics Inc Cancer Immunotherapy Products Introduction
• 5.3 Merck & Co., Inc.,
  • 5.3.1 Merck & Co., Inc., Company Profile
  • 5.3.2 Merck & Co., Inc., Business Overview
  • 5.3.3 Merck & Co., Inc., Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.3.4 Merck & Co., Inc., Cancer Immunotherapy Products Introduction
• 5.4 Novartis AG
  • 5.4.1 Novartis AG Company Profile
  • 5.4.2 Novartis AG Business Overview
  • 5.4.3 Novartis AG Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.4.4 Novartis AG Cancer Immunotherapy Products Introduction
• 5.5 Astellas Pharma Inc.
  • 5.5.1 Astellas Pharma Inc. Company Profile
  • 5.5.2 Astellas Pharma Inc. Business Overview
  • 5.5.3 Astellas Pharma Inc. Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.5.4 Astellas Pharma Inc. Cancer Immunotherapy Products Introduction
• 5.6 Celgene
  • 5.6.1 Celgene Company Profile
  • 5.6.2 Celgene Business Overview
  • 5.6.3 Celgene Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.6.4 Celgene Cancer Immunotherapy Products Introduction
• 5.7 Oncolys BioPharma
  • 5.7.1 Oncolys BioPharma Company Profile
  • 5.7.2 Oncolys BioPharma Business Overview
  • 5.7.3 Oncolys BioPharma Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.7.4 Oncolys BioPharma Cancer Immunotherapy Products Introduction
• 5.8 Otsuka Pharmaceutical Co., Ltd.
  • 5.8.1 Otsuka Pharmaceutical Co., Ltd. Company Profile
  • 5.8.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
  • 5.8.3 Otsuka Pharmaceutical Co., Ltd. Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.8.4 Otsuka Pharmaceutical Co., Ltd. Cancer Immunotherapy Products Introduction
• 5.9 Fujifilm
  • 5.9.1 Fujifilm Company Profile
  • 5.9.2 Fujifilm Business Overview
  • 5.9.3 Fujifilm Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.9.4 Fujifilm Cancer Immunotherapy Products Introduction
• 5.10 Ono Pharmaceutical Co
  • 5.10.1 Ono Pharmaceutical Co Company Profile
  • 5.10.2 Ono Pharmaceutical Co Business Overview
  • 5.10.3 Ono Pharmaceutical Co Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.10.4 Ono Pharmaceutical Co Cancer Immunotherapy Products Introduction
• 5.11 Bayer Ag
  • 5.11.1 Bayer Ag Company Profile
  • 5.11.2 Bayer Ag Business Overview
  • 5.11.3 Bayer Ag Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.11.4 Bayer Ag Cancer Immunotherapy Products Introduction
• 5.12 Eli Lilly and Company
  • 5.12.1 Eli Lilly and Company Company Profile
  • 5.12.2 Eli Lilly and Company Business Overview
  • 5.12.3 Eli Lilly and Company Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.12.4 Eli Lilly and Company Cancer Immunotherapy Products Introduction
• 5.13 Daiichi Sankyo Company Limited
  • 5.13.1 Daiichi Sankyo Company Limited Company Profile
  • 5.13.2 Daiichi Sankyo Company Limited Business Overview
  • 5.13.3 Daiichi Sankyo Company Limited Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.13.4 Daiichi Sankyo Company Limited Cancer Immunotherapy Products Introduction
• 5.14 Chugai
  • 5.14.1 Chugai Company Profile
  • 5.14.2 Chugai Business Overview
  • 5.14.3 Chugai Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.14.4 Chugai Cancer Immunotherapy Products Introduction
• 5.15 Roche Japan
  • 5.15.1 Roche Japan Company Profile
  • 5.15.2 Roche Japan Business Overview
  • 5.15.3 Roche Japan Cancer Immunotherapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.15.4 Roche Japan Cancer Immunotherapy Products Introduction

6 Market Analysis and Forecast, By Product Types

• 6.1 Global Cancer Immunotherapy Sales, Revenue and Market Share by Types (2015-2020)
  • 6.1.1 Global Cancer Immunotherapy Sales and Market Share by Types (2015-2020)
  • 6.1.2 Global Cancer Immunotherapy Revenue and Market Share by Types (2015-2020)
  • 6.1.3 Global Cancer Immunotherapy Price by Types (2015-2020)
• 6.2 Global Cancer Immunotherapy Market Forecast by Types (2020-2025)
  • 6.2.1 Global Cancer Immunotherapy Market Forecast Sales and Market Share by Types (2020-2025)
  • 6.2.2 Global Cancer Immunotherapy Market Forecast Revenue and Market Share by Types (2020-2025)
• 6.3 Global Cancer Immunotherapy Sales, Price and Growth Rate by Types (2015-2020)
  • 6.3.1 Global Cancer Immunotherapy Sales, Price and Growth Rate of Monoclonal Antibodies
  • 6.3.2 Global Cancer Immunotherapy Sales, Price and Growth Rate of Cytokines & Immunomodulators
  • 6.3.3 Global Cancer Immunotherapy Sales, Price and Growth Rate of Cancer Vaccines
  • 6.3.4 Global Cancer Immunotherapy Sales, Price and Growth Rate of Checkpoint Inhibitors
• 6.4 Global Cancer Immunotherapy Market Revenue and Sales Forecast, by Types (2020-2025)
  • 6.4.1 Monoclonal Antibodies Market Revenue and Sales Forecast (2020-2025)
  • 6.4.2 Cytokines & Immunomodulators Market Revenue and Sales Forecast (2020-2025)
  • 6.4.3 Cancer Vaccines Market Revenue and Sales Forecast (2020-2025)
  • 6.4.4 Checkpoint Inhibitors Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

• 7.1 Global Cancer Immunotherapy Sales, Revenue and Market Share by Applications (2015-2020)
  • 7.1.1 Global Cancer Immunotherapy Sales and Market Share by Applications (2015-2020)
  • 7.1.2 Global Cancer Immunotherapy Revenue and Market Share by Applications (2015-2020)
• 7.2 Global Cancer Immunotherapy Market Forecast by Applications (2020-2025)
  • 7.2.1 Global Cancer Immunotherapy Market Forecast Sales and Market Share by Applications (2020-2025)
  • 7.2.2 Global Cancer Immunotherapy Market Forecast Revenue and Market Share by Applications (2020-2025)
• 7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  • 7.3.1 Global Cancer Immunotherapy Revenue, Sales and Growth Rate of Breast Cancer (2015-2020)
  • 7.3.2 Global Cancer Immunotherapy Revenue, Sales and Growth Rate of Lung Cancer (2015-2020)
  • 7.3.3 Global Cancer Immunotherapy Revenue, Sales and Growth Rate of Colorectal Cancer (2015-2020)
  • 7.3.4 Global Cancer Immunotherapy Revenue, Sales and Growth Rate of Prostate Cancer (2015-2020)
  • 7.3.5 Global Cancer Immunotherapy Revenue, Sales and Growth Rate of Melanoma (2015-2020)
  • 7.3.6 Global Cancer Immunotherapy Revenue, Sales and Growth Rate of Head and Neck Cancer (2015-2020)
  • 7.3.7 Global Cancer Immunotherapy Revenue, Sales and Growth Rate of Others (2015-2020)
• 7.4 Global Cancer Immunotherapy Market Revenue and Sales Forecast, by Applications (2020-2025)
  • 7.4.1 Breast Cancer Market Revenue and Sales Forecast (2020-2025)
  • 7.4.2 Lung Cancer Market Revenue and Sales Forecast (2020-2025)
  • 7.4.3 Colorectal Cancer Market Revenue and Sales Forecast (2020-2025)
  • 7.4.4 Prostate Cancer Market Revenue and Sales Forecast (2020-2025)
  • 7.4.5 Melanoma Market Revenue and Sales Forecast (2020-2025)
  • 7.4.6 Head and Neck Cancer Market Revenue and Sales Forecast (2020-2025)
  • 7.4.7 Others Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

• 8.1 Global Cancer Immunotherapy Sales by Regions (2015-2020)
• 8.2 Global Cancer Immunotherapy Market Revenue by Regions (2015-2020)
• 8.3 Global Cancer Immunotherapy Market Forecast by Regions (2020-2025)

9 North America Cancer Immunotherapy Market Analysis

• 9.1 Market Overview and Prospect Analysis
• 9.2 North America Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)
• 9.3 North America Cancer Immunotherapy Market Revenue and Growth Rate (2015-2020)
• 9.4 North America Cancer Immunotherapy Market Forecast
• 9.5 The Influence of COVID-19 on North America Market
• 9.6 North America Cancer Immunotherapy Market Analysis by Country
  • 9.6.1 U.S. Cancer Immunotherapy Sales and Growth Rate
  • 9.6.2 Canada Cancer Immunotherapy Sales and Growth Rate
  • 9.6.3 Mexico Cancer Immunotherapy Sales and Growth Rate

10 Europe Cancer Immunotherapy Market Analysis

• 10.1 Market Overview and Prospect Analysis
• 10.2 Europe Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)
• 10.3 Europe Cancer Immunotherapy Market Revenue and Growth Rate (2015-2020)
• 10.4 Europe Cancer Immunotherapy Market Forecast
• 10.5 The Influence of COVID-19 on Europe Market
• 10.6 Europe Cancer Immunotherapy Market Analysis by Country
  • 10.6.1 Germany Cancer Immunotherapy Sales and Growth Rate
  • 10.6.2 United Kingdom Cancer Immunotherapy Sales and Growth Rate
  • 10.6.3 France Cancer Immunotherapy Sales and Growth Rate
  • 10.6.4 Italy Cancer Immunotherapy Sales and Growth Rate
  • 10.6.5 Spain Cancer Immunotherapy Sales and Growth Rate
  • 10.6.6 Russia Cancer Immunotherapy Sales and Growth Rate

11 Asia-Pacific Cancer Immunotherapy Market Analysis

• 11.1 Market Overview and Prospect Analysis
• 11.2 Asia-Pacific Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)
• 11.3 Asia-Pacific Cancer Immunotherapy Market Revenue and Growth Rate (2015-2020)
• 11.4 Asia-Pacific Cancer Immunotherapy Market Forecast
• 11.5 The Influence of COVID-19 on Asia Pacific Market
• 11.6 Asia-Pacific Cancer Immunotherapy Market Analysis by Country
  • 11.6.1 China Cancer Immunotherapy Sales and Growth Rate
  • 11.6.2 Japan Cancer Immunotherapy Sales and Growth Rate
  • 11.6.3 South Korea Cancer Immunotherapy Sales and Growth Rate
  • 11.6.4 Australia Cancer Immunotherapy Sales and Growth Rate
  • 11.6.5 India Cancer Immunotherapy Sales and Growth Rate

12 South America Cancer Immunotherapy Market Analysis

• 12.1 Market Overview and Prospect Analysis
• 12.2 South America Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)
• 12.3 South America Cancer Immunotherapy Market Revenue and Growth Rate (2015-2020)
• 12.4 South America Cancer Immunotherapy Market Forecast
• 12.5 The Influence of COVID-19 on South America Market
• 12.6 South America Cancer Immunotherapy Market Analysis by Country
  • 12.6.1 Brazil Cancer Immunotherapy Sales and Growth Rate
  • 12.6.2 Argentina Cancer Immunotherapy Sales and Growth Rate
  • 12.6.3 Columbia Cancer Immunotherapy Sales and Growth Rate

13 Middle East and Africa Cancer Immunotherapy Market Analysis

• 13.1 Market Overview and Prospect Analysis
• 13.2 Middle East and Africa Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)
• 13.3 Middle East and Africa Cancer Immunotherapy Market Revenue and Growth Rate (2015-2020)
• 13.4 Middle East and Africa Cancer Immunotherapy Market Forecast
• 13.5 The Influence of COVID-19 on Middle East and Africa Market
• 13.6 Middle East and Africa Cancer Immunotherapy Market Analysis by Country
  • 13.6.1 UAE Cancer Immunotherapy Sales and Growth Rate
  • 13.6.2 Egypt Cancer Immunotherapy Sales and Growth Rate
  • 13.6.3 South Africa Cancer Immunotherapy Sales and Growth Rate

14 Conclusions and Recommendations

• 14.1 Key Market Findings and Prospects
• 14.2 Advice for Investors

15 Appendix

• 15.1 Methodology
• 15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Cancer Immunotherapy Market Size and Growth Rate 2015-2025

Table Cancer Immunotherapy Key Market Segments

Figure Global Cancer Immunotherapy Market Revenue ($) Segment by Type from 2015-2020

Figure Global Cancer Immunotherapy Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Cancer Immunotherapy

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Takara Bio Company Profile

Table Takara Bio Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Takara Bio Production and Growth Rate

Figure Takara Bio Market Revenue ($) Market Share 2015-2020

Table Immunomedics Inc Company Profile

Table Immunomedics Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Immunomedics Inc Production and Growth Rate

Figure Immunomedics Inc Market Revenue ($) Market Share 2015-2020

Table Merck & Co., Inc., Company Profile

Table Merck & Co., Inc., Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Merck & Co., Inc., Production and Growth Rate

Figure Merck & Co., Inc., Market Revenue ($) Market Share 2015-2020

Table Novartis AG Company Profile

Table Novartis AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Novartis AG Production and Growth Rate

Figure Novartis AG Market Revenue ($) Market Share 2015-2020

Table Astellas Pharma Inc. Company Profile

Table Astellas Pharma Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Astellas Pharma Inc. Production and Growth Rate

Figure Astellas Pharma Inc. Market Revenue ($) Market Share 2015-2020

Table Celgene Company Profile

Table Celgene Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Celgene Production and Growth Rate

Figure Celgene Market Revenue ($) Market Share 2015-2020

Table Oncolys BioPharma Company Profile

Table Oncolys BioPharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Oncolys BioPharma Production and Growth Rate

Figure Oncolys BioPharma Market Revenue ($) Market Share 2015-2020

Table Otsuka Pharmaceutical Co., Ltd. Company Profile

Table Otsuka Pharmaceutical Co., Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Otsuka Pharmaceutical Co., Ltd. Production and Growth Rate

Figure Otsuka Pharmaceutical Co., Ltd. Market Revenue ($) Market Share 2015-2020

Table Fujifilm Company Profile

Table Fujifilm Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Fujifilm Production and Growth Rate

Figure Fujifilm Market Revenue ($) Market Share 2015-2020

Table Ono Pharmaceutical Co Company Profile

Table Ono Pharmaceutical Co Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Ono Pharmaceutical Co Production and Growth Rate

Figure Ono Pharmaceutical Co Market Revenue ($) Market Share 2015-2020

Table Bayer Ag Company Profile

Table Bayer Ag Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Bayer Ag Production and Growth Rate

Figure Bayer Ag Market Revenue ($) Market Share 2015-2020

Table Eli Lilly and Company Company Profile

Table Eli Lilly and Company Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Eli Lilly and Company Production and Growth Rate

Figure Eli Lilly and Company Market Revenue ($) Market Share 2015-2020

Table Daiichi Sankyo Company Limited Company Profile

Table Daiichi Sankyo Company Limited Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Daiichi Sankyo Company Limited Production and Growth Rate

Figure Daiichi Sankyo Company Limited Market Revenue ($) Market Share 2015-2020

Table Chugai Company Profile

Table Chugai Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Chugai Production and Growth Rate

Figure Chugai Market Revenue ($) Market Share 2015-2020

Table Roche Japan Company Profile

Table Roche Japan Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Roche Japan Production and Growth Rate

Figure Roche Japan Market Revenue ($) Market Share 2015-2020

Table Global Cancer Immunotherapy Sales by Types (2015-2020)

Table Global Cancer Immunotherapy Sales Share by Types (2015-2020)

Table Global Cancer Immunotherapy Revenue ($) by Types (2015-2020)

Table Global Cancer Immunotherapy Revenue Share by Types (2015-2020)

Table Global Cancer Immunotherapy Price ($) by Types (2015-2020)

Table Global Cancer Immunotherapy Market Forecast Sales by Types (2020-2025)

Table Global Cancer Immunotherapy Market Forecast Sales Share by Types (2020-2025)

Table Global Cancer Immunotherapy Market Forecast Revenue ($) by Types (2020-2025)

Table Global Cancer Immunotherapy Market Forecast Revenue Share by Types (2020-2025)

Figure Global Monoclonal Antibodies Sales and Growth Rate (2015-2020)

Figure Global Monoclonal Antibodies Price (2015-2020)

Figure Global Cytokines & Immunomodulators Sales and Growth Rate (2015-2020)

Figure Global Cytokines & Immunomodulators Price (2015-2020)

Figure Global Cancer Vaccines Sales and Growth Rate (2015-2020)

Figure Global Cancer Vaccines Price (2015-2020)

Figure Global Checkpoint Inhibitors Sales and Growth Rate (2015-2020)

Figure Global Checkpoint Inhibitors Price (2015-2020)

Figure Global Cancer Immunotherapy Market Revenue ($) and Growth Rate Forecast of Monoclonal Antibodies (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast of Monoclonal Antibodies (2020-2025)

Figure Global Cancer Immunotherapy Market Revenue ($) and Growth Rate Forecast of Cytokines & Immunomodulators (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast of Cytokines & Immunomodulators (2020-2025)

Figure Global Cancer Immunotherapy Market Revenue ($) and Growth Rate Forecast of Cancer Vaccines (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast of Cancer Vaccines (2020-2025)

Figure Global Cancer Immunotherapy Market Revenue ($) and Growth Rate Forecast of Checkpoint Inhibitors (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast of Checkpoint Inhibitors (2020-2025)

Table Global Cancer Immunotherapy Sales by Applications (2015-2020)

Table Global Cancer Immunotherapy Sales Share by Applications (2015-2020)

Table Global Cancer Immunotherapy Revenue ($) by Applications (2015-2020)

Table Global Cancer Immunotherapy Revenue Share by Applications (2015-2020)

Table Global Cancer Immunotherapy Market Forecast Sales by Applications (2020-2025)

Table Global Cancer Immunotherapy Market Forecast Sales Share by Applications (2020-2025)

Table Global Cancer Immunotherapy Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Cancer Immunotherapy Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Breast Cancer Sales and Growth Rate (2015-2020)

Figure Global Breast Cancer Price (2015-2020)

Figure Global Lung Cancer Sales and Growth Rate (2015-2020)

Figure Global Lung Cancer Price (2015-2020)

Figure Global Colorectal Cancer Sales and Growth Rate (2015-2020)

Figure Global Colorectal Cancer Price (2015-2020)

Figure Global Prostate Cancer Sales and Growth Rate (2015-2020)

Figure Global Prostate Cancer Price (2015-2020)

Figure Global Melanoma Sales and Growth Rate (2015-2020)

Figure Global Melanoma Price (2015-2020)

Figure Global Head and Neck Cancer Sales and Growth Rate (2015-2020)

Figure Global Head and Neck Cancer Price (2015-2020)

Figure Global Others Sales and Growth Rate (2015-2020)

Figure Global Others Price (2015-2020)

Figure Global Cancer Immunotherapy Market Revenue ($) and Growth Rate Forecast of Breast Cancer (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast of Breast Cancer (2020-2025)

Figure Global Cancer Immunotherapy Market Revenue ($) and Growth Rate Forecast of Lung Cancer (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast of Lung Cancer (2020-2025)

Figure Global Cancer Immunotherapy Market Revenue ($) and Growth Rate Forecast of Colorectal Cancer (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast of Colorectal Cancer (2020-2025)

Figure Global Cancer Immunotherapy Market Revenue ($) and Growth Rate Forecast of Prostate Cancer (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast of Prostate Cancer (2020-2025)

Figure Global Cancer Immunotherapy Market Revenue ($) and Growth Rate Forecast of Melanoma (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast of Melanoma (2020-2025)

Figure Global Cancer Immunotherapy Market Revenue ($) and Growth Rate Forecast of Head and Neck Cancer (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast of Head and Neck Cancer (2020-2025)

Figure Global Cancer Immunotherapy Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate Forecast of Others (2020-2025)

Figure Global Cancer Immunotherapy Sales and Growth Rate (2015-2020)

Table Global Cancer Immunotherapy Sales by Regions (2015-2020)

Table Global Cancer Immunotherapy Sales Market Share by Regions (2015-2020)

Figure Global Cancer Immunotherapy Sales Market Share by Regions in 2019

Figure Global Cancer Immunotherapy Revenue and Growth Rate (2015-2020)

Table Global Cancer Immunotherapy Revenue by Regions (2015-2020)

Table Global Cancer Immunotherapy Revenue Market Share by Regions (2015-2020)

Figure Global Cancer Immunotherapy Revenue Market Share by Regions in 2019

Table Global Cancer Immunotherapy Market Forecast Sales by Regions (2020-2025)

Table Global Cancer Immunotherapy Market Forecast Sales Share by Regions (2020-2025)

Table Global Cancer Immunotherapy Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Cancer Immunotherapy Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure North America Cancer Immunotherapy Market Revenue and Growth Rate (2015-2020)

Figure North America Cancer Immunotherapy Market Forecast Sales (2020-2025)

Figure North America Cancer Immunotherapy Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Canada Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Mexico Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Europe Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Europe Cancer Immunotherapy Market Revenue and Growth Rate (2015-2020)

Figure Europe Cancer Immunotherapy Market Forecast Sales (2020-2025)

Figure Europe Cancer Immunotherapy Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure France Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Italy Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Spain Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Russia Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Cancer Immunotherapy Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Cancer Immunotherapy Market Forecast Sales (2020-2025)

Figure Asia-Pacific Cancer Immunotherapy Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Japan Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure South Korea Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Australia Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure India Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure South America Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure South America Cancer Immunotherapy Market Revenue and Growth Rate (2015-2020)

Figure South America Cancer Immunotherapy Market Forecast Sales (2020-2025)

Figure South America Cancer Immunotherapy Market Forecast Revenue ($) (2020-2025)

Figure Brazil Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Argentina Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Columbia Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Cancer Immunotherapy Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Cancer Immunotherapy Market Forecast Sales (2020-2025)

Figure Middle East and Africa Cancer Immunotherapy Market Forecast Revenue ($) (2020-2025)

Figure UAE Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure Egypt Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Figure South Africa Cancer Immunotherapy Market Sales and Growth Rate (2015-2020)

Cancer immunotherapy or, immuno-oncology, is the treatment that utilises the body’s own immune system to combat cancer. These immunotherapy treatments either boost the body’s immune system or may act on immune system to identify and destroy the cancerous cells. Immunotherapy is a type of personalized medicine that works better for certain types of cancer.
Based on the Cancer Immunotherapy market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Cancer Immunotherapy market covered in Chapter 5:
Takara Bio
Immunomedics Inc
Merck & Co., Inc.,
Novartis AG
Astellas Pharma Inc.
Celgene
Oncolys BioPharma
Otsuka Pharmaceutical Co., Ltd.
Fujifilm
Ono Pharmaceutical Co
Bayer Ag
Eli Lilly and Company
Daiichi Sankyo Company Limited
Chugai
Roche Japan

In Chapter 6, on the basis of types, the Cancer Immunotherapy market from 2015 to 2025 is primarily split into:
Monoclonal Antibodies
Cytokines & Immunomodulators
Cancer Vaccines
Checkpoint Inhibitors

In Chapter 7, on the basis of applications, the Cancer Immunotherapy market from 2015 to 2025 covers:
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Melanoma
Head and Neck Cancer
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025